News

Array BioPharma (Array) has reported its preliminary analysis of results from a study examining ARRY-162, a small molecule MEK inhibitor, in a 12-week phase 2 clinical trial with

StemCells has published its preclinical data demonstrating that transplantation of its proprietary, purified human neural stem cells delays the loss of motor function in a mouse model of

Target has reported that flu vaccinations are now available at all six Target Clinic locations in Maryland. Reportedly, the vaccines offered will include flu vaccinations (ages 18 months

Commonwealth Biotechnologies (CBI) has executed an agreement to acquire all of the outstanding shares of GL Biochem (Shanghai) as well as GL Biochem (Danyang), GL Peptide (Binhai), and

Acura Pharmaceuticals (Acura) and King Pharmaceuticals (King) have met with the FDA on September 2, 2009 to discuss the agency’s Complete Response Letter regarding the New Drug Application

China Aoxing has submitted a new drug application (NDA) to the China State Food and Drug Administration (SFDA) for its Codeine Phosphate, a compound oral solution for the

NOXXON Pharma has received a research grant from Germany’s Federal Ministry of Education and Research (BMBF), under the Ministry’s small-and-medium-enterprise innovation initiative (KMU-Innovativ). The grant was presented to

Dainippon Sumitomo Pharma(DSP) and Sepracor have entered into a definitive agreement pursuant to which DSP will acquire Sepracor for approximately $2.6 billion through a cash tender offer of

Cornerstone Therapeutics has received the approval of the US Bankruptcy Court for the District of Massachusetts for its acquisition of the commercial rights to the antibiotic, Factive (gemifloxacin